Has Peter H Doubler, MD received payments from drug or device companies?

Yes. Drug and device makers reported $15,348 in general payments to Peter H Doubler, MD across 59 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Peter H Doubler, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Peter H Doubler, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Peter H Doubler, MD

Vascular Surgery · Atlanta, GANPI 1629038476

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $10,071 of the $15,348 with a category attached, or 65.6%. 7 manufacturers reported payments, led by Medtronic at 60.0% of the total. Reporting peaked in 2023 at $9,504 and has fallen 96.8% since, to $302 in 2025.

$15,348in general payments, 2019–2025

Across 59 payments — averaging $260.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$9K
Abbott$3K
W. L. Gore & Associates, Inc.$2K
Silk Road Medical, Inc.$522
Boston Scientific$390
Penumbra, Inc.$329
plus $31 from 1 others

$31,390in research payments, 2019–2025

Across 23 payments — averaging $1364.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

W. L. Gore & Associates, Inc.$31K

What the payments were for

Consulting fees$400%
Speaking & faculty fees$2,20014%
Travel & lodging$10,07166%
Food & beverage$3,03720%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	4	$9,204
Abbott	9	$2,949
W. L. Gore & Associates, Inc.	33	$1,922
Silk Road Medical, Inc.	3	$522
Boston Scientific	5	$390
Penumbra, Inc.	3	$329
AbbVie	2	$31

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,348 in reported general payments places this provider in the 75th percentile of 176 vascular surgery providers in Georgia.

See all vascular surgery providers in Georgia →

Medicare billing

Part B allowed, 2024

$341,337

Medicare patients

1,308

Services billed

2,368

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
XareltoRivaroxaban	92	$71,436
EliquisApixaban	100	$65,950
ClopidogrelClopidogrel Bisulfate	262	$2,428
Gabapentin	64	$726
Rosuvastatin Calcium	35	$316
Cilostazol	31	$270
Atorvastatin Calcium	25	$221
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	41	$211
Warfarin Sodium	19	$106
Oxycodone Hcl	11	$49
Alprazolam	24	$48
Tramadol Hcl	11	$26

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Atlanta

Siddharth PatelAtlanta$303K
Walaya Methodius-RayfordAtlanta$79K
Andrew UnzeitigAtlanta$46K
Yazan DuwayriAtlanta$44K
Anumeha WhisenhuntAtlanta$33K
James ChangAtlanta$31K
Chad AlemanAtlanta$21K
Olamide AlabiAtlanta$19K
Jorge CorsoAtlanta$18K
Eyal Ben-ArieAtlanta$14K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →